关注
David Haberl
David Haberl
Doctoral Researcher at the Medical University of Vienna
在 meduniwien.ac.at 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre …
CP Spielvogel*, D Haberl*, K Mascherbauer, J Ning, K Kluge, ...
The Lancet Digital Health 6 (4), e251-e260, 2024
42024
Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
K Kluge, D Haberl, H Einspieler, S Rasul, S Gutschmayer, L Kenner, ...
Journal of Nuclear Medicine 64 (11), 1730-1736, 2023
12023
Cardiac Amyloidosis Screening using Deep Learning on Bone Scintigraphy
CP Spielvogel, D Haberl, J Ning, K Kluge, X Li, X Ma, M Zhao, ...
Journal of Nuclear Medicine 65 (supplement 2), 241017-241017, 2024
2024
Insights from a medical algorithmic audit of a decision support system for the detection of cardiac amyloidosis on bone scintigraphy
CP Spielvogel, D Haberl, K Kluge, J Ning, M Hacker, C Nitsche
Journal of Nuclear Medicine 65 (supplement 2), 241741-241741, 2024
2024
Multicenter PET image harmonization using generative adversarial networks
D Haberl, CP Spielvogel, Z Jiang, F Orlhac, D Iommi, I Carrió, I Buvat, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-15, 2024
2024
Comparison of discovery rates and prognostic utility of [68Ga] Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer—a cross-sectional study
K Kluge, H Einspieler, D Haberl, C Spielvogel, D Amereller, G Egger, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-10, 2024
2024
Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [68Ga]Ga-PSMA-11-PET Examinations
H Einspieler, K Kluge, D Haberl, K Schatz, L Nics, S Schmitl, BK Geist, ...
Cancers 16 (8), 1514, 2024
2024
Prognose und Screening nach kardialer Amyloidose in der Knochenszintigrafie durch künstliche Intelligenz: Eine internationale, multizentrische, Tracer-übergreiffende Studie
CP Spielvogel, D Haberl, J Ning, K Kluge, T Traub-Weidinger, T Nakuz, ...
Nuklearmedizin-NuclearMedicine 63 (02), L03, 2024
2024
Quantum Image Analysis in PSMA-11 PET/CT Primary Prostate Patients
L Papp, D Haberl, M Hacker, W Drexler, S Moradi
Nuklearmedizin-NuclearMedicine 63 (02), V65, 2024
2024
Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective–Prospective [68Ga …
K Kluge, H Einspieler, D Haberl, C Spielvogel, S Stoiber, C Vraka, L Papp, ...
Journal of Nuclear Medicine 65 (1), 63-70, 2024
2024
DEBI-NN: Distance-encoding biomorphic-informational neural networks for minimizing the number of trainable parameters
L Papp, D Haberl, B Ecsedi, CP Spielvogel, D Krajnc, M Grahovac, ...
Neural Networks 167, 517-532, 2023
2023
Association between blood-derived circulating-tumor DNA and ⁶⁸Ga-PSMA-HBED-CC PET/CT findings
K Kluge, H Einspieler, D Haberl, C Spielvogel, S Stoiber, M Hacker, ...
Journal of Nuclear Medicine 64 (supplement 1), P679-P679, 2023
2023
Multimodal risk assessment of Hodgkin lymphoma patients in a dual-center study
D Haberl, K Girum, O Kulterer, AS Cottereau, Z Jiang, L Rebaud, A Flotats, ...
Journal of Nuclear Medicine 64 (supplement 1), P1082-P1082, 2023
2023
Multicentric PET Image Harmonization utilizing Generative Adversarial Networks
D Haberl, D Iommi, C Spielvogel, I Buvat, A Haug, L Papp
Journal of Nuclear Medicine 64 (supplement 1), P1184-P1184, 2023
2023
A machine learning system for Gleason grading of prostate cancer improves patient stratification for radical prostatectomy: a multiomics diagnostic study
J Ning, C Spielvogel, K Tractova, D Haberl, S Rasul, S Stoiber, V Bystry, ...
Journal of Nuclear Medicine 64 (supplement 1), P594-P594, 2023
2023
Associations between antihormonal-treatment status and ⁶⁸Ga-PSMA-HBED-CC PET biodistribution
K Kluge, H Einspieler, D Haberl, S Gutschmayer, L Kenner, A Haug, ...
Journal of Nuclear Medicine 64 (supplement 1), P688-P688, 2023
2023
Annotation-free deep representation learning enables automated transthyretin cardiac amyloidosis detection on 99mTc scans
C Spielvogel, D Haberl, T Traub-Weidinger, M Zhao, X Ma, J Ning, ...
Journal of Nuclear Medicine 64 (supplement 1), P256-P256, 2023
2023
A novel approach for identifying NSCLC recurrence and metastases after radical resection using [18F] FDG-PET/CT
Z Jiang, D Haberl, LKS Sundar, J Yu, C Spielvogel, L Kenner, A Haug
Journal of Nuclear Medicine 64 (supplement 1), P1245-P1245, 2023
2023
Deep representation learning enables automated high-grade cardiac amyloidosis detection on Tc-99m-DPD scans
D Haberl, CP Spielvogel, M Hacker, G Goliasch, C Nitsche
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022
2022
Stratification of Hodgkin lymphoma patients using metabolic tumor burden and tumor dissemination calculated from baseline [18F] FDG-PET/CT imaging
K Girum, AS Cottereau, D Haberl, L Papp, L Rebaud, M Hacker, T Beyer, ...
Journal of Nuclear Medicine 63 (supplement 2), 3123-3123, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20